Back to Search
SHEILA GUJRATHI, M.D.
M.D.
Internal Medicine Physician
NPI: 1114113156Individual
Specialties, Licenses & Credentials
Research & Publications (4)
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
PMID 18759293·Arthritis Rheum·2008
3-trial
TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma.
PMID 16870656·Eur Respir J·2006
8-other
Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.
PMID 16200815·Ann Allergy Asthma Immunol·2005
4-observational
Filmless in New Jersey: the New Jersey Medical School PACS Project.
PMID 12105690·J Digit Imaging·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 50 IVY ST
SAN FRANCISCO, CA 94102 - Phone
- (415) 355-7400
Quick Facts
- NPI
- 1114113156
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 4
Are you this provider?
Claim Your Profile